Joanna Gajuk
Stock Analyst at B of A Securities
(3.32)
# 1,200
Out of 4,944 analysts
31
Total ratings
63.64%
Success rate
12.16%
Average return
Main Sectors:
Stocks Rated by Joanna Gajuk
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CHE Chemed | Maintains: Buy | $708 → $650 | $450.36 | +44.33% | 1 | Jun 30, 2025 | |
| CON Concentra Group Holdings Parent | Maintains: Buy | $24 → $25 | $22.86 | +9.36% | 4 | Jan 23, 2025 | |
| USPH U.S. Physical Therapy | Upgrades: Buy | $100 → $115 | $88.52 | +29.91% | 3 | Dec 16, 2024 | |
| BTSG BrightSpring Health Services | Maintains: Buy | $19 → $21 | $22.39 | -6.21% | 2 | Dec 11, 2024 | |
| BKD Brookdale Senior Living | Downgrades: Underperform | $7.75 → $6 | $7.39 | -18.81% | 2 | Oct 7, 2024 | |
| SEM Select Medical Holdings | Reinstates: Buy | $42 | $12.67 | +231.49% | 1 | Aug 20, 2024 | |
| EHAB Enhabit | Maintains: Underperform | $9 → $8 | $7.57 | +5.68% | 2 | Jun 27, 2024 | |
| ADUS Addus HomeCare | Maintains: Buy | $115 → $118 | $116.56 | +1.24% | 2 | May 7, 2024 | |
| AHCO AdaptHealth | Maintains: Neutral | $13 → $11 | $9.73 | +13.05% | 2 | Sep 22, 2023 | |
| AMED Amedisys | Downgrades: Underperform | $145 → $102 | $100.98 | +1.01% | 8 | Jun 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $10 → $5.5 | $7.15 | -23.08% | 1 | Mar 29, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $46 → $48 | $82.05 | -41.50% | 3 | Feb 21, 2018 |
Chemed
Jun 30, 2025
Maintains: Buy
Price Target: $708 → $650
Current: $450.36
Upside: +44.33%
Concentra Group Holdings Parent
Jan 23, 2025
Maintains: Buy
Price Target: $24 → $25
Current: $22.86
Upside: +9.36%
U.S. Physical Therapy
Dec 16, 2024
Upgrades: Buy
Price Target: $100 → $115
Current: $88.52
Upside: +29.91%
BrightSpring Health Services
Dec 11, 2024
Maintains: Buy
Price Target: $19 → $21
Current: $22.39
Upside: -6.21%
Brookdale Senior Living
Oct 7, 2024
Downgrades: Underperform
Price Target: $7.75 → $6
Current: $7.39
Upside: -18.81%
Select Medical Holdings
Aug 20, 2024
Reinstates: Buy
Price Target: $42
Current: $12.67
Upside: +231.49%
Enhabit
Jun 27, 2024
Maintains: Underperform
Price Target: $9 → $8
Current: $7.57
Upside: +5.68%
Addus HomeCare
May 7, 2024
Maintains: Buy
Price Target: $115 → $118
Current: $116.56
Upside: +1.24%
AdaptHealth
Sep 22, 2023
Maintains: Neutral
Price Target: $13 → $11
Current: $9.73
Upside: +13.05%
Amedisys
Jun 21, 2022
Downgrades: Underperform
Price Target: $145 → $102
Current: $100.98
Upside: +1.01%
Mar 29, 2022
Downgrades: Neutral
Price Target: $10 → $5.5
Current: $7.15
Upside: -23.08%
Feb 21, 2018
Maintains: Buy
Price Target: $46 → $48
Current: $82.05
Upside: -41.50%